Bausch + Lomb Corporation (NYSE:BLCO) Given Consensus Rating of “Hold” by Brokerages

Bausch + Lomb Corporation (NYSE:BLCO) has been assigned an average rating of “Hold” from the fifteen analysts that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, ten have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $18.25.

Several analysts have recently weighed in on BLCO shares. Royal Bank Of Canada boosted their price target on Bausch + Lomb from $19.00 to $21.00 and gave the stock an “outperform” rating in a report on Tuesday, January 27th. Barclays lifted their target price on shares of Bausch + Lomb from $17.00 to $20.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 19th. HC Wainwright boosted their target price on shares of Bausch + Lomb from $17.00 to $20.00 and gave the stock a “buy” rating in a report on Monday, February 23rd. Weiss Ratings restated a “sell (d-)” rating on shares of Bausch + Lomb in a research report on Wednesday, January 21st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $18.00 price target on shares of Bausch + Lomb in a research note on Thursday, February 19th.

Insider Activity at Bausch + Lomb

In related news, CEO Brent L. Saunders bought 14,700 shares of the stock in a transaction that occurred on Friday, March 6th. The stock was acquired at an average cost of $17.14 per share, with a total value of $251,958.00. Following the transaction, the chief executive officer directly owned 966,575 shares in the company, valued at approximately $16,567,095.50. This trade represents a 1.54% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP A Robert D. Bailey bought 14,600 shares of the business’s stock in a transaction on Friday, March 6th. The shares were bought at an average cost of $17.15 per share, for a total transaction of $250,390.00. Following the completion of the acquisition, the executive vice president directly owned 231,890 shares in the company, valued at approximately $3,976,913.50. This trade represents a 6.72% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased 33,300 shares of company stock worth $570,868 over the last three months. Company insiders own 0.15% of the company’s stock.

Institutional Trading of Bausch + Lomb

Several institutional investors have recently added to or reduced their stakes in BLCO. Caitong International Asset Management Co. Ltd increased its position in Bausch + Lomb by 104.1% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,227 shares of the company’s stock valued at $38,000 after purchasing an additional 1,136 shares during the period. Northwestern Mutual Wealth Management Co. raised its holdings in Bausch + Lomb by 729.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,322 shares of the company’s stock worth $30,000 after purchasing an additional 2,042 shares during the last quarter. Wells Fargo & Company MN lifted its position in shares of Bausch + Lomb by 31.2% in the 4th quarter. Wells Fargo & Company MN now owns 5,903 shares of the company’s stock worth $101,000 after purchasing an additional 1,403 shares during the period. Jones Financial Companies Lllp lifted its position in shares of Bausch + Lomb by 55.3% in the 3rd quarter. Jones Financial Companies Lllp now owns 9,112 shares of the company’s stock worth $132,000 after purchasing an additional 3,246 shares during the period. Finally, Invesco Ltd. bought a new stake in shares of Bausch + Lomb in the 4th quarter valued at $178,000. 11.07% of the stock is currently owned by institutional investors.

Bausch + Lomb Trading Down 0.8%

NYSE BLCO opened at $15.24 on Tuesday. The company has a market cap of $5.41 billion, a price-to-earnings ratio of -14.94, a price-to-earnings-growth ratio of 0.64 and a beta of 0.58. Bausch + Lomb has a twelve month low of $10.45 and a twelve month high of $18.92. The company has a quick ratio of 1.04, a current ratio of 1.55 and a debt-to-equity ratio of 0.77. The business’s fifty day moving average is $16.98 and its 200 day moving average is $16.31.

Bausch + Lomb (NYSE:BLCO) last issued its earnings results on Wednesday, February 18th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.03). The firm had revenue of $1.41 billion during the quarter, compared to analyst estimates of $1.38 billion. Bausch + Lomb had a positive return on equity of 2.77% and a negative net margin of 7.06%.Bausch + Lomb’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.25 EPS. As a group, sell-side analysts expect that Bausch + Lomb will post 0.74 EPS for the current fiscal year.

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief.